利索-全球专利检索

  1. Login
  2. Sign Up

Search Results

5379 records (took 0.027 seconds)

    COMPOSITION AND METHOD OF IMPROVING COGNITION
    1.
    发明申请
    COMPOSITION AND METHOD OF IMPROVING COGNITION 有权

    公开(公告)号：US20250064880A1

    公开(公告)日：2025-02-27

    申请号：US18718785

    申请日：2022-12-14

    Applicant: BERRY LAB AB

    Inventor： Lovisa HEYMAN-LINDÉN ,  Nittaya MARUNGRUANG ,  Fang HUANG ,  Rickard ÖSTE

    IPC: A61K36/45 ,  A61K36/185 ,  A61K36/73 ,  A61P25/28

    Abstract: The invention provides a composition comprising disintegrated whole bilberry (Vaccinium myrtillus) berries and disintegrated whole lingonberry (Vaccinium vitis-idaca) berries, wherein the bilberry berries and lingonberry berries are disintegrated by homogenization. A method of manufacturing the composition, as well as a method of amelioration of a cognitive function, such as cognition, memory, and working memory, in a healthy human subject, are also provided. It is suggested that figure IA is published with the abstract

    Flavor elements and methods of providing nonvaporized flavor to electronic vaporizers and E-cigarettes
    2.
    发明授权
    Flavor elements and methods of providing nonvaporized flavor to electronic vaporizers and E-cigarettes 有权

    公开(公告)号：US12232523B2

    公开(公告)日：2025-02-25

    申请号：US18301804

    申请日：2023-04-17

    Applicant: Darren Rubin

    Inventor： Darren Rubin

    IPC: A24F40/30 ,  A23G3/34 ,  A24B15/167 ,  A24F40/20 ,  A61K31/05 ,  A61K31/352 ,  A61K36/185

    Abstract: The present disclosure describes a flavor element configured for providing flavor to a user of an electronic vaporizer, along with nicotine reduction methods. The flavor element includes a flavor material configured to provide the flavor and is configured to attach to the electronic vaporizer. When attached to the electronic vaporizer and during inhalation by the user using the electronic vaporizer, the flavor element is configured to provide the flavor to the user in parallel with an inhalable aerosol provided by the electronic vaporizer. The inhalable aerosol is provided by the electronic vaporizer by at least partially vaporizing a vaporizable substance via a vapor element. The flavor provided via the flavor material is separate from the vaporizable substance.

    PHARMACEUTICAL COMBINATION FOR TREATING OR PREVENTING EPILEPSY AND THE USE THEREOF
    3.
    发明申请
    PHARMACEUTICAL COMBINATION FOR TREATING OR PREVENTING EPILEPSY AND THE USE THEREOF 有权

    公开(公告)号：US20250049871A1

    公开(公告)日：2025-02-13

    申请号：US18446761

    申请日：2023-08-09

    Applicant: FU JEN CATHOLIC UNIVERSITY

    Inventor： SU-JANE WANG ,  CHI-FENG HUNG

    IPC: A61K36/185 ,  A61K31/55 ,  A61P25/08

    Abstract: The present disclosure provides a birch (Betula platyphylla) sap extract combination for treating or preventing epilepsy and use in the preparation a medication. The medication may further include other medications or ingredients to enhance the anti-epileptic effects. The combination of the present disclosure has the characteristics of high efficiency, safety, and convenience, and can effectively treat or prevent epilepsy while reducing medication side effects. The present disclosure also provides a method of treating or preventing epilepsy with the combination.

    Anti-aging therapy for canines and other domesticated animals
    7.
    发明授权
    Anti-aging therapy for canines and other domesticated animals 有权

    公开(公告)号：US12201589B2

    公开(公告)日：2025-01-21

    申请号：US17676486

    申请日：2022-02-21

    Applicant: Richard Postrel

    Inventor： Richard Postrel

    IPC: A61K31/05 ,  A23K10/30 ,  A23K20/111 ,  A23K20/158 ,  A23K20/184 ,  A23K50/40 ,  A61K31/568 ,  A61K36/185 ,  A61P5/00

    Abstract: The present invention discloses a system and method for improving the quality of life in canines and other domesticated animals. As animals age testosterone and other supportive hormones diminish causing reduced activity, a lack of mobility, decreased bone density, and general well-being. Precursor compositions are selected and designed for the purpose of formulating non-toxic therapeutic hormone supplements for oral consumption. The process and method of this invention is comprised of therapies produced from two or more selected non-toxic prohormones that combine during digestion and delivered through a chewable and edible gummy treat. As such there is no requirement for changing the subject's current diet. The present invention features a continuous low dose supplementation to be incorporated daily whereby dosages are correlated according to the subject's age, weight, sex, and breed. The beneficial results of the present invention are achieved through the absorption of the prohormones in the composition into the bloodstream effecting delivery to all cells including those specific cells where the conversion enzymes are activated by the organism's needs. The delivery and transport of inactive prohormones minimizes liver toxicity since the precursors are carried through the hepatic portal system to and through the liver and into general circulation in inactive forms.

    Method of production of phytocannabinoids for use in medical treatments
    10.
    发明授权
    Method of production of phytocannabinoids for use in medical treatments 有权

    公开(公告)号：US12185684B2

    公开(公告)日：2025-01-07

    申请号：US18061328

    申请日：2022-12-02

    Applicant: CELL SCIENCE HOLDING LTD

    Inventor： Peter Andrew Whitton

    IPC: A01H4/00 ,  A01H3/02 ,  A01H6/28 ,  A61K31/352 ,  A61K36/185 ,  C12N5/04

    Abstract: A method of producing cannabinoids for use in medical treatments by growing cultured Cannabis sativa plant cells through tissue culture, the method comprising the steps of: selecting Cannabis sativa leaf tissue for culture; and growing a tissue culture from the selected leaf tissue in a liquid based medium whilst controlling the light exposure of the tissue culture to control the cannabinoid content of the tissue culture. Control of the light exposure can enable the phytocannabinoid content of the grown tissue culture to be tailored to the use intended for the tissue culture. For example, the THC content of the tissue culture can be controlled to be maximised or minimised depending on the intended use. Use of tissue culture is beneficial as compared to prior art methods as it allows for genetic consistency and reduces the resources necessary to produce plant cells containing phytocannabinoids.

Patent Agency Ranking